Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

IZEA acquires online influencer platform TapInfluence in a US$7.08mln deal

The platform connects marketers with online influencers such as bloggers or Instagram celebrities
IZEA acquires online influencer platform TapInfluence in a US$7.08mln deal
The soon-to-be-acquired start-up has more than 87,000 registered users

IZEA Inc (NASDAQ:IZEA) has reached a multi-million dollar agreement to acquire TapInfluence Inc, a rival marketing platform.

The Silicon Valley-based start-up is a software-as-a-service-based online marketplace with more than 87,000 registered users. Its user base consists of online influencers such as bloggers and Instagram celebrities. The platform connects marketers with influencers to promote their products or services.

Shares of IZEA soared nearly 90% to US$1.76 in Thursday pre-market trading.

TapInfluence claims that the average monthly influencer cash compensation totals US$763.50. The company has worked with big-name brands like Panasonic and SunTrust.

READ: Synergy CHC turns to Instagram influencers to promote its products

The part-cash, part-stock transaction is estimated to be worth around US$7.08mln.

IZEA runs a similar marketplace with more than 700,000 registered creators.

“We are bringing together two of the leading companies in the influencer marketing space, creating an influencer marketing offering that is unparalleled in the industry, and providing the critical mass necessary for making significant inroads on several fronts,” said IZEA CEO Ted Murphy in a press release.

The merger is expected to be completed before the end of July.

View full IZEA profile View Profile

Related Articles

August 15 2018
Milan Patel, dotdigital’s chief executive officer said: "This year reflects substantial progress against the company's strategic aims in accelerating our platform capabilities into the omnichannel space, continuing to innovate our product, growing geographically and deepening our relationships with our strategic partners”
According to Liberum, FFI expects the US performance to normalise by the end of this financial year
September 19 2018
“Cello Health is successfully building its early stage asset development advisory platform for biotech clients, as well as growing its core later stage and post-launch franchise with pharmaceutical clients”

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use